Continuation vs discontinuation of antiplatelet therapy
All‐cause mortality (up to 30 days) · adults undergoing non‐cardiac surgery
Continuation showed no clear difference in all‐cause mortality (up to 30 days) compared with discontinuation of antiplatelet therapy (low certainty).
1 finding from 1 review
- Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing… 2018 · Cochrane Headline outcomes onlyRR 1.21 [0.34, 4.27]4 studies · 616 participantsLow